Abstract:A recent letter to The Lancet1Xi B Zhou C Zhang M Wang Y Xu L Maternal and child mortality in China.Lancet. 2014; 383: 953-954Summary Full Text Full Text PDF PubMed Scopus (20) Google Scholar drew attention to Chinese achievements with regard to Millennium Development Goals (MDGs) 4 and 5. The wide wealth and health disparities, including in maternal survival, in China, linked both to the urban–rural divide and to the east–west divide, have been noted many times.2Tang S Meng Q Chen L Bekedam H Evans T Whitehead M Tackling the challenges to health equity in China.Lancet. 2008; 372: 1493-1501Summary Full Text Full Text PDF PubMed Scopus (380) Google Scholar, 3Liang J Dai L Zhu J et al.Preventable maternal mortality: geographic/rural-urban differences and associated factors from the population-based Maternal Mortality Surveillance System in China.BMC Public Health. 2011; 11: 243Crossref PubMed Scopus (42) Google Scholar Here we draw attention to the closing gap between urban and rural maternal mortality ratio (MMR), both in terms of the drivers behind the dramatic drop in rural maternal mortality and the surprising lack of improvement in urban maternal mortality. The drop in rural maternal mortality coincides with the launch of the New Cooperative Medical Scheme (NCMS) in 2003. The scheme operates on a voluntary basis and pools funds from central and local governments, with individual contributions.4Wang YZ Development of the New Rural Cooperative Medical System in China.China World Econ. 2007; 15: 66-77Crossref Scopus (24) Google Scholar The maternity package offered under NCMS varies across counties,5Long Q Zhang Y Raven J et al.Giving birth at a health-care facility in rural China: is it affordable for the poor?.Bull World Health Organ. 2011; 89: 144-152Crossref PubMed Scopus (25) Google Scholar but it typically offers subsidies of expenses for facility-based delivery including antenatal and postnatal services, either as a prepayment or a retrospective reimbursement. In 2011, 97·5% of rural villages were enrolled in the NCMS.6Chinese Ministry of HealthChinese health service development statistics bulletin.http://www.nhfpc.gov.cn/mohwsbwstjxxzx/s7967/201204/54532.shtmlGoogle Scholar Since launch, the officially reported MMR in rural China decreased from 65·4 per 100 000 in 2003 to 26·5 per 100 000 in 2011,6Chinese Ministry of HealthChinese health service development statistics bulletin.http://www.nhfpc.gov.cn/mohwsbwstjxxzx/s7967/201204/54532.shtmlGoogle Scholar, 7Chinese Ministry of HealthYearbook of health statistics in China.http://www.nhfpc.gov.cn/htmlfiles/zwgkzt/ptjnj/year2012/index2012.htmlGoogle Scholar reaching almost the same level as the urban MMR (25·2 per 100 000 in 2011; figure). Rising hospital delivery rates were financially supported not only by NCMS, but also by other local, regional, and national programmes, especially a national Ministry of Health program called “Reducing Maternal Mortality and Eliminating Neonatal Tetanus”, launched in 2000. This programme included subsidies for hospital delivery as well as interventions to improve quality of obstetric services in hospitals. Out-of-pocket expenditure on a facility-based delivery as a percentage of annual household income decreased from 2002 to 2007. Having health insurance was associated with reduced out-of-pocket expenditure, particularly on a caesarean delivery.7Chinese Ministry of HealthYearbook of health statistics in China.http://www.nhfpc.gov.cn/htmlfiles/zwgkzt/ptjnj/year2012/index2012.htmlGoogle Scholar Elective caesarean delivery rates are reported to be higher among NCMS participants than among non-participants.8Huang K Tao F Raven J Liu L Wu X Tang S Utilization of antenatal ultrasound scan and implications for caesarean section: a cross-sectional study in rural Eastern China.BMC Health Serv Res. 2012; 12: 93Crossref PubMed Scopus (20) Google Scholar In the 8 years preceding the launch of NCMS (1994–2002) the urban MMR in China fell to a greater extent (−49·4%) than did the rural MMR (−24·9%); however, in the years subsequent to the launch of the NCMS (2003–11), rural MMR fell by 59·5% whereas the urban MMR was only reduced by 3·3% (figure). In the same period (2003–10), annual income per head in urban China rose sharply from 8400 to 19 000 CNY, whereas in rural China the rise was more modest, from 2600 to 5900 CNY (figure). Are these maternal mortality data reliable? Researchers have reported discrepancies between routine data and survey data related to the number of reported livebirths and to reported infant, child, and maternal mortality, as well as to maternal and child health interventions.9Wang L Wang LJ Cai Y Ma LM Zhou MG Analysis of under-reporting of mortality surveillance from 2006 to 2008 in China.Chi J Prev Med. 2011; 45 (in Chinese).: 1061-1064Google Scholar Du and colleagues10Du Q Naess Ö Bjertness E Yang G.H Wng LH Kumar BN Differences in reporting maternal and child health indicators: a comparison between routine and survey data in Guizhou Province.Int J of Women's Health. 2012; 4: 294-303Google Scholar found that coverage of most maternal and child health indicators in the study areas in Guizhou were lower than in the routine data, and deaths were under-reported. The researchers concluded that monitoring and evaluation for MDG goals 4 and 5 will remain objective and reliable only if estimates are based on good reporting systems. Mander11Lu L Li X The effects of the new-type rural cooperative medical system on reducing the mortality of the pregnant and lying-in women in China.Med Inform. 2010; 5 (in Chinese).: 2985-2986Google Scholar noted that a potential criticism against the reported achievements in reducing MMR relates to the authenticity of the data presented. She noted that there are issues linked to the fact that meeting government targets is connected to rewards and punishments. Chen and Xu12Chen L Xu D Trends in China's reforms: the Rashomon effect.Lancet. 2012; 379: 782-783Summary Full Text Full Text PDF PubMed Scopus (11) Google Scholar noted in The Lancet the conflicting findings from studies of the impact of NCMS. These reservations notwithstanding, it is important to call attention to the dramatic reduction in rural MMR in China and the lack of progress in the urban MMR. The levelling out of urban maternal mortality in China in the past decade calls for increased attention. A possible cause could be the influx of migrant workers and other floating population, who lack resources and access to adequate services. We declare no competing interests. This work was supported by the MATIND project, funded by the European Union (261304). The views expressed in the paper are those of the authors. We thank the masters students at Zhejiang University, School of Public Health, involved in the MATIND project team (Shengnan Duan, Yuan Wu, Chiyu Ye, Xiaofang Liu) for their support in the data collection. Maternal and child mortality in ChinaMaternal and child mortality is an important indicator of a country's health and development. In 2000, 189 governments committed to eight development goals for 2015.1 The target of Millennium Development Goal (MDG) 4 was to reduce mortality in children younger than 5 years by two-thirds between 1990 and 2015, and the target for MDG5 was to reduce the maternal mortality ratio by three-quarters during the same period. In 2008, the Countdown to 2015 initiative identified 68 priority countries (including China) for accelerated action on maternal, newborn, and child health. Full-Text PDF

Abstract:Background: Future trends in disease burden and drivers of health are of great interest to policy makers and the public at large. This information can be used for policy and long-term health investment, planning, and prioritisation. We have expanded and improved upon previous forecasts produced as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) and provide a reference forecast (the most likely future), and alternative scenarios assessing disease burden trajectories if selected sets of risk factors were eliminated from current levels by 2050. Methods: Using forecasts of major drivers of health such as the Socio-demographic Index (SDI; a composite measure of lag-distributed income per capita, mean years of education, and total fertility under 25 years of age) and the full set of risk factor exposures captured by GBD, we provide cause-specific forecasts of mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) by age and sex from 2022 to 2050 for 204 countries and territories, 21 GBD regions, seven super-regions, and the world. All analyses were done at the cause-specific level so that only risk factors deemed causal by the GBD comparative risk assessment influenced future trajectories of mortality for each disease. Cause-specific mortality was modelled using mixed-effects models with SDI and time as the main covariates, and the combined impact of causal risk factors as an offset in the model. At the all-cause mortality level, we captured unexplained variation by modelling residuals with an autoregressive integrated moving average model with drift attenuation. These all-cause forecasts constrained the cause-specific forecasts at successively deeper levels of the GBD cause hierarchy using cascading mortality models, thus ensuring a robust estimate of cause-specific mortality. For non-fatal measures (eg, low back pain), incidence and prevalence were forecasted from mixed-effects models with SDI as the main covariate, and YLDs were computed from the resulting prevalence forecasts and average disability weights from GBD. Alternative future scenarios were constructed by replacing appropriate reference trajectories for risk factors with hypothetical trajectories of gradual elimination of risk factor exposure from current levels to 2050. The scenarios were constructed from various sets of risk factors: environmental risks (Safer Environment scenario), risks associated with communicable, maternal, neonatal, and nutritional diseases (CMNNs; Improved Childhood Nutrition and Vaccination scenario), risks associated with major non-communicable diseases (NCDs; Improved Behavioural and Metabolic Risks scenario), and the combined effects of these three scenarios. Using the Shared Socioeconomic Pathways climate scenarios SSP2-4.5 as reference and SSP1-1.9 as an optimistic alternative in the Safer Environment scenario, we accounted for climate change impact on health by using the most recent Intergovernmental Panel on Climate Change temperature forecasts and published trajectories of ambient air pollution for the same two scenarios. Life expectancy and healthy life expectancy were computed using standard methods. The forecasting framework includes computing the age-sex-specific future population for each location and separately for each scenario. 95% uncertainty intervals (UIs) for each individual future estimate were derived from the 2·5th and 97·5th percentiles of distributions generated from propagating 500 draws through the multistage computational pipeline. Findings: In the reference scenario forecast, global and super-regional life expectancy increased from 2022 to 2050, but improvement was at a slower pace than in the three decades preceding the COVID-19 pandemic (beginning in 2020). Gains in future life expectancy were forecasted to be greatest in super-regions with comparatively low life expectancies (such as sub-Saharan Africa) compared with super-regions with higher life expectancies (such as the high-income super-region), leading to a trend towards convergence in life expectancy across locations between now and 2050. At the super-region level, forecasted healthy life expectancy patterns were similar to those of life expectancies. Forecasts for the reference scenario found that health will improve in the coming decades, with all-cause age-standardised DALY rates decreasing in every GBD super-region. The total DALY burden measured in counts, however, will increase in every super-region, largely a function of population ageing and growth. We also forecasted that both DALY counts and age-standardised DALY rates will continue to shift from CMNNs to NCDs, with the most pronounced shifts occurring in sub-Saharan Africa (60·1% [95% UI 56·8-63·1] of DALYs were from CMNNs in 2022 compared with 35·8% [31·0-45·0] in 2050) and south Asia (31·7% [29·2-34·1] to 15·5% [13·7-17·5]). This shift is reflected in the leading global causes of DALYs, with the top four causes in 2050 being ischaemic heart disease, stroke, diabetes, and chronic obstructive pulmonary disease, compared with 2022, with ischaemic heart disease, neonatal disorders, stroke, and lower respiratory infections at the top. The global proportion of DALYs due to YLDs likewise increased from 33·8% (27·4-40·3) to 41·1% (33·9-48·1) from 2022 to 2050, demonstrating an important shift in overall disease burden towards morbidity and away from premature death. The largest shift of this kind was forecasted for sub-Saharan Africa, from 20·1% (15·6-25·3) of DALYs due to YLDs in 2022 to 35·6% (26·5-43·0) in 2050. In the assessment of alternative future scenarios, the combined effects of the scenarios (Safer Environment, Improved Childhood Nutrition and Vaccination, and Improved Behavioural and Metabolic Risks scenarios) demonstrated an important decrease in the global burden of DALYs in 2050 of 15·4% (13·5-17·5) compared with the reference scenario, with decreases across super-regions ranging from 10·4% (9·7-11·3) in the high-income super-region to 23·9% (20·7-27·3) in north Africa and the Middle East. The Safer Environment scenario had its largest decrease in sub-Saharan Africa (5·2% [3·5-6·8]), the Improved Behavioural and Metabolic Risks scenario in north Africa and the Middle East (23·2% [20·2-26·5]), and the Improved Nutrition and Vaccination scenario in sub-Saharan Africa (2·0% [-0·6 to 3·6]). Interpretation: Globally, life expectancy and age-standardised disease burden were forecasted to improve between 2022 and 2050, with the majority of the burden continuing to shift from CMNNs to NCDs. That said, continued progress on reducing the CMNN disease burden will be dependent on maintaining investment in and policy emphasis on CMNN disease prevention and treatment. Mostly due to growth and ageing of populations, the number of deaths and DALYs due to all causes combined will generally increase. By constructing alternative future scenarios wherein certain risk exposures are eliminated by 2050, we have shown that opportunities exist to substantially improve health outcomes in the future through concerted efforts to prevent exposure to well established risk factors and to expand access to key health interventions. Funding: Bill & Melinda Gates Foundation.

MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells.

NICU NURSES' KNOWLEDGE AND DISCHARGE TEACHING RELATED TO INFANT SLEEP POSITION AND RISK OF SIDS

Ending Preventable Neonatal Deaths: Multicountry Evidence to Inform Accelerated Progress to the Sustainable Development Goal by 2030

Global child mortality falls to historic low

CAEP 2014 Academic Symposium: "How to make research succeed in your department: Promoting excellence in Canadian emergency medicine resident research".

Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study

Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016

Estimates of neonatal morbidities and disabilities at regional and global levels for 2010: introduction, methods overview, and relevant findings from the Global Burden of Disease study

Distributed Resource Adaptation for Virtual Network Operators

Rural Maternal Mortality Ratio in China.

Proton therapy for tumors of the skull base

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015

Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016

Trends for Neonatal Deaths in Nepal (2001-2016) to Project Progress Towards the SDG Target in 2030, and Risk Factor Analyses to Focus Action

Luteinization and proteolysis in ovarian follicles of Meishan and Large White gilts during the preovulatory period.

Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

Age distribution, trends, and forecasts of under-5 mortality in 31 sub-Saharan African countries: A modeling study.

Neonatal mortality in countries of the Americas, 2000-2020: trends, inequalities, and target-setting

Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021

Mapping 123 million neonatal, infant and child deaths between 2000 and 2017